Count | |
| 1 | |
| 4 | |
| 3 | |
| 1 | |
| 1 | |
| 42 | |
| 39 | |
| 8 | |
| 11 | |
| 1 | |
| 1 | |
| 15 | |
| 2 | |
| 29 | |
| 4 | |
| 1 | |
| 1 | |
| 5 | |
| 17 | |
| 371 | |
| 3 | |
| 15 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 1 | |
| 51 | |
| 19 | |
| 1 | |
| 4 | |
| 1 | |
| 19 | |
| 3 | |
| 2 | |
| 3 | |
| 16 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 32 | |
| 577 | |
| 4 | |
| 553 | |
| 21 | |
| 10 | |
| 4 | |
| 9 | |
| 4 | |
| 24 | |
| 13 | |
| 1 | |
| 3 | |
| 1 | |
| 8 | |
| 16 | |
| 3 | |
| 1 | |
| 1 | |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |